vimarsana.com
  1. Home
  2. Live Updates
  3. Drugs Take Center Stage In Myeloma - Breaking News

Latest Breaking News On - Drugs take center stage in myeloma - Page 1 : vimarsana.com

Janssen: New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pre-treated Patients with Multiple Myeloma

Phase 1b results of teclistamab in combination with DARZALEX? (daratumumab) subcutaneous (SC) also presented at ASH 2021 Annual Meeting1,2 The Janssen Pharmaceutical Companies of Johnson Johnson

United statesNoah reymondYusri elsayedEdmond chan mbchPhilippe moreauJessica mooreJanssen biotech incAmerican society of hematology annual meetingAmerican society of clinical oncologyCancer research instituteDrugs take center stage in myelomaJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonAmerican society of hematologyUniversity hospital

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.